The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis
Open accessAbstract
The Hippo signaling pathway, also known as the Salvador–Warts–Hippo pathway, is a regulator of organ size. The pathway takes its name from the Drosophila protein kinase, Hippo (STK4/MST1 and STK3/MST2 in mammals), which, when inactivated, leads to considerable tissue overgrowth. In mammals, MST1 and MST2 negatively regulate the transcriptional co-activators yes-associated protein 1 (YAP) and WW domain containing transcription regulator 1 (WWTR1/TAZ), which together regulate the expression of genes that control proliferation, survival, and differentiation. YAP and TAZ activation have been associated with liver development, regeneration, and tumorigenesis. How their activity is dynamically regulated in these contexts, however, is just beginning to be elucidated. We review the mechanisms of Hippo signaling in the liver and explore outstanding questions for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Aragona, M., Panciera, T., Manfrin, A., Giulitti, S., Michielin, F., Elvassore, N., Dupont, S., & Piccolo, S. (2013) · Cell · doi:10.1016/j.cell.2013.07.042 · Cited by 1,651
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Liver regeneration: from myth to mechanism
Taub, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1489 · Cited by 1,567
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452
Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., et al. (1993) · Nature · doi:10.1038/363515a0 · Cited by 1,420
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
Trofatter, J. (1993) · Cell · doi:10.1016/0092-8674(93)90406-g · Cited by 1,403
YAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252
Self-citationGenome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Zanconato, F., Forcato, M., Battilana, G., Azzolin, L., Quaranta, E., Bodega, B., Rosato, A., Bicciato, S., Cordenonsi, M., & Piccolo, S. (2015) · Nature Cell Biology · doi:10.1038/ncb3216 · Cited by 1,219
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Yap1 acts downstream of α-catenin to control epidermal proliferation
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.031 · Cited by 1,036
Self-citationA novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913
Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon
Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C.-X., Brugge, J. S., & Haber, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605579103 · Cited by 885
Hippo Pathway Activity Influences Liver Cell Fate
Yimlamai, D., Christodoulou, C., Galli, G. G., Yanger, K., Pepe-Mooney, B., Gurung, B., Shrestha, K., Cahan, P., Stanger, B. Z., & Camargo, F. D. (2014) · Cell · doi:10.1016/j.cell.2014.03.060 · Cited by 857
Self-citationJeon, H., Lee, H., Kang, K. H., & Lim, G. (2014) · Scientific Reports · doi:10.1038/srep06668 · Cited by 844
Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804
Kanai, F., Marignani, P. A., Sarbassova, D., Yagi, R., Hall, R. A., Donowitz, M., Hisaminato, A., Fujiwara, T., Ito, Y., Cantley, L. C., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6778 · Cited by 756
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Lu, L., Li, Y., Kim, S. M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G., Finegold, M. J., Lee, J.-S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911427107 · Cited by 721
Liver Regeneration after Partial Hepatectomy
Michalopoulos, G. K. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090675 · Cited by 713
Alternative Wnt Signaling Activates YAP/TAZ
Park, H. W., Kim, Y. C., Yu, B., Moroishi, T., Mo, J.-S., Plouffe, S. W., Meng, Z., Lin, K. C., Yu, F.-X., Alexander, C. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.013 · Cited by 705
Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver
Wang, B., Zhao, L., Fish, M., Logan, C. Y., & Nusse, R. (2015) · Nature · doi:10.1038/nature14863 · Cited by 674
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Zhao, B., Li, L., Lu, Q., Wang, L. H., Liu, C.-Y., Lei, Q., & Guan, K.-L. (2011) · Genes & Development · doi:10.1101/gad.2000111 · Cited by 665
The role of hepatocytes and oval cells in liver regeneration and repopulation
Fausto, N., & Campbell, J. S. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00338-6 · Cited by 648
Wu, S., Liu, Y., Zheng, Y., Dong, J., & Pan, D. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.007 · Cited by 640
The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control
Zhang, L., Ren, F., Zhang, Q., Chen, Y., Wang, B., & Jiang, J. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.006 · Cited by 630
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.010 · Cited by 602
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Song, H., Mak, K. K., Topol, L., Yun, K., Hu, J., Garrett, L., Chen, Y., Park, O., Chang, J., Simpson, R. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911409107 · Cited by 583
Sia, D., Hoshida, Y., Villanueva, A., Roayaie, S., Ferrer, J., Tabak, B., Peix, J., Sole, M., Tovar, V., Alsinet, C., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.001 · Cited by 575
A WW domain-containing Yes-associated protein (YAP) is a novel transcriptional co-activator
Yagi, R., Chen, L.-F., Shigesada, K., Murakami, Y., & Ito, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2551 · Cited by 558
Expression of Yes-associated protein in common solid tumors
Steinhardt, A. A., Gayyed, M. F., Klein, A. P., Dong, J., Maitra, A., Pan, D., Montgomery, E. A., & Anders, R. A. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.04.012 · Cited by 552
Apc Tumor Suppressor Gene Is the “Zonation-Keeper” of Mouse Liver
Benhamouche, S., Decaens, T., Godard, C., Chambrey, R., Rickman, D. S., Moinard, C., Vasseur-Cognet, M., Kuo, C. J., Kahn, A., Perret, C., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.015 · Cited by 543
Restriction of intestinal stem cell expansion and the regenerative response by YAP
Barry, E. R., Morikawa, T., Butler, B. L., Shrestha, K., de la Rosa, R., Yan, K. S., Fuchs, C. S., Magness, S. T., Smits, R., Ogino, S., et al. (2013) · Nature · doi:10.1038/nature11693 · Cited by 543
Self-citationYes‐associated protein is an independent prognostic marker in hepatocellular carcinoma
Xu, M. Z., Yao, T., Lee, N. P. Y., Ng, I. O. L., Chan, Y., Zender, L., Lowe, S. W., Poon, R. T. P., & Luk, J. M. (2009) · Cancer · doi:10.1002/cncr.24495 · Cited by 528
Yin, F., Yu, J., Zheng, Y., Chen, Q., Zhang, N., & Pan, D. (2013) · Cell · doi:10.1016/j.cell.2013.08.025 · Cited by 504
Lee, K.-P., Lee, J.-H., Kim, T.-S., Kim, T.-H., Park, H.-D., Byun, J.-S., Kim, M.-C., Jeong, W.-I., Calvisi, D. F., Kim, J.-M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912203107 · Cited by 493
Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer
Font-Burgada, J., Shalapour, S., Ramaswamy, S., Hsueh, B., Rossell, D., Umemura, A., Taniguchi, K., Nakagawa, H., Valasek, M. A., Ye, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.026 · Cited by 486
YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
Tumaneng, K., Schlegelmilch, K., Russell, R. C., Yimlamai, D., Basnet, H., Mahadevan, N., Fitamant, J., Bardeesy, N., Camargo, F. D., & Guan, K.-L. (2012) · Nature Cell Biology · doi:10.1038/ncb2615 · Cited by 453
Self-citationGoulev, Y., Fauny, J. D., Gonzalez-Marti, B., Flagiello, D., Silber, J., & Zider, A. (2008) · Current Biology · doi:10.1016/j.cub.2008.02.034 · Cited by 452
Notch signaling controls liver development by regulating biliary differentiation
Zong, Y., Panikkar, A., Xu, J., Antoniou, A., Raynaud, P., Lemaigre, F., & Stanger, B. Z. (2009) · Development · doi:10.1242/dev.029140 · Cited by 444
Hyperproliferation and Defects in Epithelial Polarity upon Conditional Ablation of α-Catenin in Skin
Vasioukhin, V., Bauer, C., Degenstein, L., Wise, B., & Fuchs, E. (2001) · Cell · doi:10.1016/s0092-8674(01)00246-x · Cited by 435
Morin-Kensicki, E. M., Boone, B. N., Howell, M., Stonebraker, J. R., Teed, J., Alb, J. G., Magnuson, T. R., O'Neal, W., & Milgram, S. L. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.77-87.2006 · Cited by 429
The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
Mannaerts, I., Leite, S. B., Verhulst, S., Claerhout, S., Eysackers, N., Thoen, L. F. R., Hoorens, A., Reynaert, H., Halder, G., & van Grunsven, L. A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.011 · Cited by 410
Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
Chan, S. W., Lim, C. J., Chong, Y. F., Pobbati, A. V., Huang, C., & Hong, W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.212621 · Cited by 386
Fernandez-L, A., Northcott, P. A., Dalton, J., Fraga, C., Ellison, D., Angers, S., Taylor, M. D., & Kenney, A. M. (2009) · Genes & Development · doi:10.1101/gad.1824509 · Cited by 377
The cholangiopathies: Disorders of biliary epithelia
Lazaridis, K. N., Strazzabosco, M., & LaRusso, N. F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.006 · Cited by 372
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
Moroishi, T., Park, H. W., Qin, B., Chen, Q., Meng, Z., Plouffe, S. W., Taniguchi, K., Yu, F.-X., Karin, M., Pan, D., et al. (2015) · Genes & Development · doi:10.1101/gad.262816.115 · Cited by 369
The RSPO–LGR4/5–ZNRF3/RNF43 module controls liver zonation and size
Planas-Paz, L., Orsini, V., Boulter, L., Calabrese, D., Pikiolek, M., Nigsch, F., Xie, Y., Roma, G., Donovan, A., Marti, P., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3337 · Cited by 359
Tschaharganeh, D. F., Chen, X., Latzko, P., Malz, M., Gaida, M. M., Felix, K., Ladu, S., Singer, S., Pinna, F., Gretz, N., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.009 · Cited by 326
Tao, J., Calvisi, D. F., Ranganathan, S., Cigliano, A., Zhou, L., Singh, S., Jiang, L., Fan, B., Terracciano, L., Armeanu–Ebinger, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.004 · Cited by 317
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
Zhang, X., George, J., Deb, S., Degoutin, J. L., Takano, E. A., Fox, S. B., AOCS Study group, Bowtell, D. D. L., & Harvey, K. F. (2011) · Oncogene · doi:10.1038/onc.2011.8 · Cited by 309
Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1
Hossain, Z., Ali, S. M., Ko, H. L., Xu, J., Ng, C. P., Guo, K., Qi, Z., Ponniah, S., Hong, W., & Hunziker, W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605266104 · Cited by 297
Zhang, W., Gao, Y., Li, P., Shi, Z., Guo, T., Li, F., Han, X., Feng, Y., Zheng, C., Wang, Z., et al. (2014) · Cell Research · doi:10.1038/cr.2014.10 · Cited by 296
A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway
Mohseni, M., Sun, J., Lau, A., Curtis, S., Goldsmith, J., Fox, V. L., Wei, C., Frazier, M., Samson, O., Wong, K.-K., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2884 · Cited by 294
Self-citationMakita, R., Uchijima, Y., Nishiyama, K., Amano, T., Chen, Q., Takeuchi, T., Mitani, A., Nagase, T., Yatomi, Y., Aburatani, H., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00201.2007 · Cited by 293
YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers
Galli, G. G., Carrara, M., Yuan, W.-C., Valdes-Quezada, C., Gurung, B., Pepe-Mooney, B., Zhang, T., Geeven, G., Gray, N. S., de Laat, W., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.001 · Cited by 290
Self-citationRegulation of the Hippo–YAP pathway by protease-activated receptors (PARs)
Mo, J.-S., Yu, F.-X., Gong, R., Brown, J. H., & Guan, K.-L. (2012) · Genes & Development · doi:10.1101/gad.197582.112 · Cited by 282
Lin, C.-W., Chang, Y.-L., Chang, Y.-C., Lin, J.-C., Chen, C.-C., Pan, S.-H., Wu, C.-T., Chen, H.-Y., Yang, S.-C., Hong, T.-M., et al. (2013) · Nature Communications · doi:10.1038/ncomms2876 · Cited by 281
Challenges to Liver Transplantation and Strategies to Improve Outcomes
Dutkowski, P., Linecker, M., DeOliveira, M. L., Müllhaupt, B., & Clavien, P.-A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.08.045 · Cited by 270
Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
Wang, W., Huang, J., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.205401 · Cited by 269
Nf2 /Merlin controls progenitor homeostasis and tumorigenesis in the liver
Benhamouche, S., Curto, M., Saotome, I., Gladden, A. B., Liu, C.-H., Giovannini, M., & McClatchey, A. I. (2010) · Genes & Development · doi:10.1101/gad.1938710 · Cited by 269
Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
Hall, C. A., Wang, R., Miao, J., Oliva, E., Shen, X., Wheeler, T., Hilsenbeck, S. G., Orsulic, S., & Goode, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1242 · Cited by 263
Yi, C., Troutman, S., Fera, D., Stemmer-Rachamimov, A., Avila, J. L., Christian, N., Persson, N. L., Shimono, A., Speicher, D. W., Marmorstein, R., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.017 · Cited by 260
Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad
Nejak-Bowen, K. N., & Monga, S. P. S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.010 · Cited by 260
Emerging roles of Notch signaling in liver disease
Geisler, F., & Strazzabosco, M. (2015) · Hepatology · doi:10.1002/hep.27268 · Cited by 249
Hofmann, J. J., Zovein, A. C., Koh, H., Radtke, F., Weinmaster, G., & Iruela-Arispe, M. L. (2010) · Development · doi:10.1242/dev.052118 · Cited by 249
YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression
Fitamant, J., Kottakis, F., Benhamouche, S., Tian, H. S., Chuvin, N., Parachoniak, C. A., Nagle, J. M., Perera, R. M., Lapouge, M., Deshpande, V., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.027 · Cited by 248
Identification of Serum-Derived Sphingosine-1-Phosphate as a Small Molecule Regulator of YAP
Miller, E., Yang, J., DeRan, M., Wu, C., Su, A. I., Bonamy, G. M. C., Liu, J., Peters, E. C., & Wu, X. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.005 · Cited by 246
YAP activation is an early event and a potential therapeutic target in liver cancer development
Perra, A., Kowalik, M. A., Ghiso, E., Ledda-Columbano, G. M., Di Tommaso, L., Angioni, M. M., Raschioni, C., Testore, E., Roncalli, M., Giordano, S., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.033 · Cited by 240
Marti, P., Stein, C., Blumer, T., Abraham, Y., Dill, M. T., Pikiolek, M., Orsini, V., Jurisic, G., Megel, P., Makowska, Z., et al. (2015) · Hepatology · doi:10.1002/hep.27992 · Cited by 232
Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth
Cox, A. G., Hwang, K. L., Brown, K. K., Evason, K. J., Beltz, S., Tsomides, A., O’Connor, K., Galli, G. G., Yimlamai, D., Chhangawala, S., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3389 · Cited by 215
Self-citationHansen, C. G., Ng, Y. L. D., Lam, W.-L. M., Plouffe, S. W., & Guan, K.-L. (2015) · Cell Research · doi:10.1038/cr.2015.140 · Cited by 212
Cholangiocyte proliferation and liver fibrosis
Glaser, S. S., Gaudio, E., Miller, T., Alvaro, D., & Alpini, G. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000994 · Cited by 204
Lee, D.-H., Park, J. O., Kim, T.-S., Kim, S.-K., Kim, T.-H., Kim, M.-C., Park, G. S., Kim, J.-H., Kuninaka, S., Olson, E. N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11961 · Cited by 196
Bile Acids Activate YAP to Promote Liver Carcinogenesis
Anakk, S., Bhosale, M., Schmidt, V. A., Johnson, R. L., Finegold, M. J., & Moore, D. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.030 · Cited by 196
Transcriptional Coactivation of Bone-Specific Transcription Factor Cbfa1 by TAZ
Cui, C. B., Cooper, L. F., Yang, X., Karsenty, G., & Aukhil, I. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1004-1013.2003 · Cited by 195
Zhao, B., Kim, J., Ye, X., Lai, Z.-C., & Guan, K.-L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2997 · Cited by 192
Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b -deficient mice
Nishio, M., Sugimachi, K., Goto, H., Wang, J., Morikawa, T., Miyachi, Y., Takano, Y., Hikasa, H., Itoh, T., Suzuki, S. O., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517188113 · Cited by 192
Zhang, T., Zhang, J., You, X., Liu, Q., Du, Y., Gao, Y., Shan, C., Kong, G., Wang, Y., Yang, X., et al. (2012) · Hepatology · doi:10.1002/hep.25899 · Cited by 182
Apte, U., Gkretsi, V., Bowen, W. C., Mars, W. M., Luo, J.-H., Donthamsetty, S., Orr, A., Monga, S. P. S., Wu, C., & Michalopoulos, G. K. (2009) · Hepatology · doi:10.1002/hep.23059 · Cited by 174
Gladden, A. B., Hebert, A. M., Schneeberger, E. E., & McClatchey, A. I. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.10.008 · Cited by 172
Yi, C., Shen, Z., Stemmer-Rachamimov, A., Dawany, N., Troutman, S., Showe, L. C., Liu, Q., Shimono, A., Sudol, M., Holmgren, L., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004060 · Cited by 168
Deregulation of Hippo kinase signalling in Human hepatic malignancies
Li, H., Wolfe, A., Septer, S., Edwards, G., Zhong, X., Bashar Abdulkarim, A., Ranganathan, S., & Apte, U. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02646.x · Cited by 168
Yes-associated protein regulates the hepatic response after bile duct ligation
Bai, H., Zhang, N., Xu, Y., Chen, Q., Khan, M., Potter, J. J., Nayar, S. K., Cornish, T., Alpini, G., Bronk, S., et al. (2012) · Hepatology · doi:10.1002/hep.25769 · Cited by 166
Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice
Nishio, M., Hamada, K., Kawahara, K., Sasaki, M., Noguchi, F., Chiba, S., Mizuno, K., Suzuki, S. O., Dong, Y., Tokuda, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63735 · Cited by 166
TRIB2 Acts Downstream of Wnt/TCF in Liver Cancer Cells to Regulate YAP and C/EBPα Function
Wang, J., Park, J.-S., Wei, Y., Rajurkar, M., Cotton, J. L., Fan, Q., Lewis, B. C., Ji, H., & Mao, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.013 · Cited by 159
Park, Y., Sohn, B. H., Johnson, R. L., Kang, M., Kim, S. B., Shim, J., Mangala, L. S., Kim, J. H., Yoo, J. E., Rodriguez‐Aguayo, C., et al. (2015) · Hepatology · doi:10.1002/hep.28223 · Cited by 159
Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration
Grijalva, J. L., Huizenga, M., Mueller, K., Rodriguez, S., Brazzo, J., Camargo, F., Sadri-Vakili, G., & Vakili, K. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00077.2014 · Cited by 158
Self-citationYAP is a critical oncogene in human cholangiocarcinoma
Pei, T., Li, Y., Wang, J., Wang, H., Liang, Y., Shi, H., Sun, B., Yin, D., Sun, J., Song, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4043 · Cited by 154
Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP
Chen, Q., Zhang, N., Xie, R., Wang, W., Cai, J., Choi, K.-S., David, K. K., Huang, B., Yabuta, N., Nojima, H., et al. (2015) · Genes & Development · doi:10.1101/gad.264234.115 · Cited by 147
Yamada, D., Ilyas, S. I., Razumilava, N., Bronk, S. F., Davila, J. I., Champion, M. D., Borad, M. J., Bezerra, J. A., Chen, X., & Gores, G. J. (2015) · Hepatology · doi:10.1002/hep.27687 · Cited by 145
Wu, H., Xiao, Y., Zhang, S., Ji, S., Wei, L., Fan, F., Geng, J., Tian, J., Sun, X., Qin, F., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.020 · Cited by 140
Self-citationLKB1 tumor suppressor protein: PARtaker in cell polarity
Baas, A. F., Smit, L., & Clevers, H. C. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.04.001 · Cited by 139
Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model
Armengol, C., Cairo, S., Fabrè, M., & Buendia, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.012 · Cited by 137
Hayashi, H., Higashi, T., Yokoyama, N., Kaida, T., Sakamoto, K., Fukushima, Y., Ishimoto, T., Kuroki, H., Nitta, H., Hashimoto, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0291 · Cited by 136
Role of Lgl/Dlg/Scribble in the regulation of epithelial junction, polarity and growth
Yamanaka, T., & Ohno, S. (2008) · Frontiers in bioscience · doi:10.2741/3182 · Cited by 131
Yang, C., Graves, H. K., Moya, I. M., Tao, C., Hamaratoǧlu, F., Gladden, A. B., & Halder, G. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420850112 · Cited by 128
Hedgehog regulates yes‐associated protein 1 in regenerating mouse liver
Swiderska‐Syn, M., Xie, G., Michelotti, G. A., Jewell, M. L., Premont, R. T., Syn, W., & Diehl, A. M. (2016) · Hepatology · doi:10.1002/hep.28542 · Cited by 127
Links between α-catenin, NF-κB, and squamous cell carcinoma in skin
Kobielak, A., & Fuchs, E. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510422103 · Cited by 124
Sohn, B. H., Shim, J., Kim, S.-B., Jang, K. Y., Kim, S. M., Kim, J. H., Hwang, J., Jang, H.-J., Lee, H., Kim, S.-C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1447 · Cited by 124
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation
Aylon, Y., Gershoni, A., Rotkopf, R., Biton, I. E., Porat, Z., Koh, A. P., Sun, X., Lee, Y., Fiel, M.-I., Hoshida, Y., et al. (2016) · European Journal of Cancer · doi:10.1016/s0959-8049(16)61580-0 · Cited by 109
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
Higashi, T., Hayashi, H., Ishimoto, T., Takeyama, H., Kaida, T., Arima, K., Taki, K., Sakamoto, K., Kuroki, H., Okabe, H., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.170 · Cited by 105
Xiao, H., Jiang, N., Zhou, B., Liu, Q., & Du, C. (2014) · Cancer Science · doi:10.1111/cas.12587 · Cited by 89
Nguyen, H. B., Babcock, J. T., Wells, C. D., & Quilliam, L. A. (2013) · Oncogene · doi:10.1038/onc.2012.431 · Cited by 84
Split Liver Transplantation: An Overview
Emre, S., & Umman, V. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.02.036 · Cited by 83
Zhang, K., Chang, Y., Shi, Z., Han, X., Han, Y., Yao, Q., Hu, Z., Cui, H., Zheng, L., Han, T., et al. (2016) · Scientific Reports · doi:10.1038/srep30029 · Cited by 76
Mitamura, T., Watari, H., Wang, L., Kanno, H., Kitagawa, M., Hassan, M. K., Kimura, T., Tanino, M. A., Nishihara, H., Tanaka, S., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-97 · Cited by 67
miR-375 Inhibits Proliferation of Mouse Pancreatic Progenitor Cells by Targeting YAP1
Zhang, Z., Men, T., Feng, R.-C., Li, Y.-C., Zhou, D., & Teng, C. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356614 · Cited by 60
Halim, V. A., Álvarez‐Fernández, M., Xu, Y. J., Aprelia, M., van den Toorn, H., Heck, A. J. R., Mohammed, S., & Medema, R. H. (2013) · Science Signaling · doi:10.1126/scisignal.2003664 · Cited by 60
Size mismatch in liver transplantation
Fukazawa, K., & Nishida, S. (2016) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.371 · Cited by 51
Loss of α-catenin elicits a cholestatic response and impairs liver regeneration
Herr, K. J., Tsang, Y. N., Ong, J., Li, Q., Yap, L. L., Yu, W., Yin, H., Bogorad, R. L., Dahlman, J. E., Chan, Y. G., et al. (2014) · Scientific Reports · doi:10.1038/srep06835 · Cited by 50
Dong, J. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.640 · Cited by 46
Bai, H., Zhu, Q., Surcel, A., Luo, T., Ren, Y., Guan, B., Liu, Y., Wu, N., Joseph, N. E., Wang, T., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00027.2016 · Cited by 43
Kim, J., Kang, D., Long, L. Z., Huang, S.-M., Yeo, M., Yi, E. S., & Kim, K. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.08.003 · Cited by 39
Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies
Bai, H., Gayyed, M. F., Lam-Himlin, D. M., Klein, A. P., Nayar, S. K., Xu, Y., Khan, M. A., Argani, P., Pan, D., & Anders, R. A. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.12.001 · Cited by 37
(1988) · PubMed · Cited by 31
Wang, Y., Cui, R., Zhang, X., Qiao, Y., Liu, X., Chang, Y.-F., Yu, Y., Sun, F., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.7022 · Cited by 28
Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions
Reis, H., Bertram, S., Pott, L. L., Canbay, A. E., Gallinat, A., & Baba, H. A. (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0079-0 · Cited by 8
Cited by
Liver regeneration: biological and pathological mechanisms and implications
Michalopoulos, G. K., & Bhushan, B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0342-4 · Cited by 998
Hippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Moya, I. M., & Halder, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0086-y · Cited by 981
The roles of signaling pathways in bone repair and regeneration
Majidinia, M., Sadeghpour, A., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26042 · Cited by 513
YAP and TAZ: a signalling hub of the tumour microenvironment
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0168-y · Cited by 381
Defining Driver DNA Methylation Changes in Human Cancer
Pfeifer, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041166 · Cited by 323
Metadata
- Authors
- Patel, S. H., Camargo, F. D., & Yimlamai, D.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 152
- Issue
- 3
- Pages
- 533-545
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2562001879
- Cited by
- 297
- References
- 127
- FWCI
- 15.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.